3,000 cancer patients to help unlock secrets of drug resistance
NCT ID NCT03572192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect tissue and blood samples from 3,000 adults with solid tumors to learn why cancers spread and become resistant to treatments. Researchers will use advanced lab tests to find molecular defects that drive cancer growth. The goal is to use this knowledge to develop better treatments and tests in the future. Participants will donate samples taken during routine medical procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St Bartholomew's Hospital
RECRUITINGLondon, EC1A 7BE, United Kingdom
Contact
Contact Phone: •••-•••-••••
Contact